medline.ch Respirationstrakt Neoplasie

	Landmark ctDNA molecular response represents an early predictor of immunotherapy outcomes in lung cancer: A clinical validity study. Clin Cancer Res Niknafs N, Sivapalan L, Balan A, Wehr J, Pereira G, Hosseini-Nami S, Rao N, Jolly S, Velliangiri K, Beadles I, Loftus T, Chesnick B, Medina J, Xiao W, Pabani A, Marrone KA, Li QK, Murray JC, Rinaldi L, Dracopoli NC, Sausen M, Hann CL, Scott SC, Feliciano J, Lam VK, Levy B, Velculescu VE, Brahmer JR, Forde PM, Vellanki PJ, Anagnostou V. PMID: 42489696 [PubMed - as supplied by publisher]
	Recent advances in EGFR-targeted therapies for non-small cell lung cancer. Expert Opin Pharmacother Lucente L, Barcellini L, Ramella Pollone B, Filipazzi CL, Coco S, Puppo M, Marconi S, Santamaria S, Tagliamento M, Rossi G, Dellepiane C, Bennicelli E, Barletta G, Zinoli L, Genova C. PMID: 42489649 [PubMed - as supplied by publisher]
	Diagnostic Performance of Radial EBUS-Guided Cryobiopsy for Peripheral Lung Lesions: First Experience in Morocco. Clin Respir J Chrif Morand L, Bouti K, Saidi I, Fdil S, Rafik A. PMID: 42489183 [PubMed - indexed for MEDLINE]
	Safety and Efficacy of Aumolertinib as First-Line Treatment in EGFR-Mutant Lung Adenosquamous Carcinoma: A Multicenter, Single-Arm, Prospective Phase II Study (ARISE Study). MedComm (2020) Zhang L, Huang L, Huang D, Liu Z, Yu Y, Miao K, Miao Q, Zheng X, Xu Y, Chu Q, Lin G. PMID: 42488708 [PubMed]
	Prognostic significance of continuing immunotherapy beyond progression in unresectable lung adenocarcinoma. Front Immunol Hu F, Zheng L, Xu H, Pan F, Nie W, Zhong R, Lou Y, Han B, Zheng X, Zhong H, Zhang X. PMID: 42488667 [PubMed - indexed for MEDLINE]
	Innovative use of therapeutic antibodies in lung cancer: the current landscape of ADCs and other antibody-based therapies. Front Oncol Lee M, Lovly CM. PMID: 42488115 [PubMed]
	Development and validation of an interpretable machine learning model for venous thromboembolism risk prediction in patients with lung cancer: a real-world study. Front Med (Lausanne) Xia A, Liu J, Song J, Han Y, Ding B, Xie A, Liu C, Tang X, Xing W, Zhou D, Liu L, Zhou H. PMID: 42487960 [PubMed]
	Radiomics-based machine learning to evaluate immunotherapy efficacy in non-small cell lung cancer patients with bone metastases. J Med Imaging (Bellingham) Kakavand R, Forkert ND, Abbott A, Kendal J, Connell P, Yashar H, Monument MJ, Edwards WB. PMID: 42487876 [PubMed]
	Insulinoma-associated Protein-1 as a Biomarker for Diagnosis of Small Cell Lung Cancer: A Meta-analysis. Pak J Med Sci Zhai J, Qin B, Zhai J, Wang J. PMID: 42487865 [PubMed]
	Adherence to a diet with higher protein quality significantly reduces the risk of lung cancer: results from a population-based prospective study. Front Public Health Shu N, Peng L, Luo Y, Wang Y, Feng D, Zeng L, Tang J. PMID: 42487825 [PubMed - indexed for MEDLINE]
	Integrated approach of guided honest disclosure and palliative care for advanced lung cancer: impacts on emotional distress, symptom burden, and patient satisfaction. Front Public Health Huo H, Wei J, Zhang X, Li Y, Zhu X, Liu Y. PMID: 42487810 [PubMed - indexed for MEDLINE]
	Relationship Between the Proportion of CD24+ CD27+ B Cells And Lung Adenocarcinoma: Evidence From Mendelian Randomization And Single-Cell Analyses. Curr Med Chem Zhong P, Chen J, Song T, Chen L, Lu Z, Peng S, Zhu X, Ding X, Kong P, Wen J, Zeng Y, Xiong C, Liu Y, Liu H, Huang H. PMID: 42487590 [PubMed - as supplied by publisher]
	Descriptive analysis of screen-detected versus clinically diagnosed lung cancer cases: evidence of earlier stage shift and treatment differences. Intern Med J Guayco Sigcha J, Chee TM, Yang IA, Passmore L, Fong KM, Marshall HM. PMID: 42487222 [PubMed - as supplied by publisher]
	Cost-Effectiveness and Budget Impact of Lung Cancer Screening: A Systematic Review. Pharmacoeconomics Chen N, Wang S, Bai J, Franchini F, Winn KM, Hu J, Wang J, Chen G. PMID: 42487098 [PubMed - as supplied by publisher]
	First Measurement: Proactively Sparing the Immune System During SBRT to Early-Stage Lung Cancer-A Randomized Phase II Study. Int J Radiat Oncol Biol Phys Wijesooriya K, Nguyen C, Conaway MR, Read PW, Romano K, Lum LG, Thakur A, Lain DW, McLaughlin CM, Luminais CK, Wood S, Williams G, Chen J, Walker B, Sprouts D, Muller D, Ward K, Dutta S, Sanders J, Cousins D, Asare E, Nesbit E, Chavis YC, Walker KV, Janowski E, Showalter T, Larner JM. PMID: 42486309 [PubMed - as supplied by publisher]
	Efficacy and Safety of Canakinumab Compared With Standard Therapy for the Treatment of Non-Small Cell Lung Cancer (NSCLC): A Systematic Review. Cancer Rep (Hoboken) Izadpanah K, Rezaei M, Nejadghaderi SA, Sharifi H. PMID: 42486074 [PubMed - indexed for MEDLINE]
	Impact of Lack of Access to Immunotherapy on Survival in Stage IV Non-Small Cell Lung Cancer: A Multicenter Retrospective Study From Lebanon. JCO Glob Oncol Hodroj MH, Numan H, El-Halabi L, Rammal F, Ghais A, Tfayli R, Orm AB, Charafeddine M, Orm CB, Haddad K, Seif S, Ghanem H, El-Hachem G, El Karak F, Farhat F, Safa M, Khuri FR, Tfayli A. PMID: 42485593 [PubMed - indexed for MEDLINE]
	IL-6/IL-6R-Mediated Mechanisms in Lung Cancer: From Pathogenesis to Potential Therapeutic Targets. Immunology Abuhassan Q, Al-Ameer HJ, Jyothi SR, Nayak PP, Prakash P, Mukherjee G, Sinha A, Hazratkulova O. PMID: 42484541 [PubMed - as supplied by publisher]
	Pharmacoeconomic Analysis of Osimertinib Compared to Earlier-Generation EGFR Inhibitors in EGFR-Mutated NSCLC: A Systematic Review. Cancer Med Perrotta N, Coluccia A, Rossi F, Amato G, Polito G. PMID: 42484063 [PubMed - indexed for MEDLINE]
	Near Infrared Photoimmunotherapy for Lung Cancer: Recent Development and Perspective. Immunotargets Ther Okada R, Yamada M, Sato M, Sato K. PMID: 42483566 [PubMed]

Artikel 1 - 20 / 161710

Seite 1 von 8086



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung